What are the risks of investing in TARS?
T
What are the risks of investing in TARS?
🦉
Tarsus Pharmaceuticals, Inc. (TARS)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOBobak R. Azamian
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused...
Key Executives
| Name | Title |
|---|---|
| Adrienne Kemp | Senior Director of Corporate Communications |
| Aziz Mottiwala | Chief Commercial Officer |
| Bobak R. Azamian | Co-Founder, President, Chief Executive Officer & Chairman |
| Bryan Wahl | General Counsel & Corporate Secretary |
| Cara Miller | Senior Vice President of Corporate Affairs |
| David Nakasone | Head of Investor Relations |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A